Keyphrases
Indonesia
100%
Hepatocellular Carcinoma
89%
Liver Cirrhosis
64%
Hepatitis C Virus
41%
Endoscopic Ultrasound
40%
Non-alcoholic Fatty Liver Disease (NAFLD)
37%
Transient Elastography
35%
APASL
28%
Asian Pacific Association for the Study of the Liver
28%
Antiretroviral Therapy
26%
Portal Hypertension
25%
Cirrhosis
25%
Acute-on-chronic Liver Failure
24%
Hepatitis B Virus
24%
Clinical Practice Guidelines
23%
Hepatitis C
23%
Chronic Liver Disease
22%
Hepatitis C Virus Infection
22%
Hepatocellular Carcinoma Patients
22%
Liver Disease
21%
Liver Fibrosis
21%
Esophageal Varices
20%
Alpha-fetoprotein
19%
COVID-19
17%
Jakarta
17%
Co-infected Patients
17%
Chronic Hepatitis C
16%
Consensus Recommendations
16%
Liver
16%
Controlled Attenuation Parameter
16%
HIV-HCV
16%
α1-acid Glycoprotein
15%
AIDS/HIV
15%
Chronic Hepatitis B Patients
13%
Risk Factors
13%
Hepatitis B Virus Infection
13%
Tertiary Referral Hospital
12%
Clinical Practice
12%
Cirrhotic Patients
12%
Metabolic-associated Fatty Liver Disease (MAFLD)
12%
Fibrosis
12%
Ultrasound Examination
12%
Asia
11%
Hepatitis C Virus Genotypes
11%
Therapeutic Endoscopic Ultrasound
11%
Sofosbuvir
11%
M2BPGi
11%
Lessons Learned
11%
Steatosis
11%
Disease Burden
10%
Medicine and Dentistry
Hepatocellular Carcinoma
83%
Liver Cirrhosis
68%
Endoscopic Ultrasound
43%
Hepatitis B
31%
Portal Hypertension
30%
Nonalcoholic Fatty Liver
29%
Transient Elastography
29%
Esophageal Varices
28%
Fibrosis
28%
Patient Referral
25%
Hepatitis C Virus
20%
Infection
20%
Hepatitis B Virus
20%
Chronic Liver Disease
20%
COVID-19
19%
Liver Disease
18%
Liver Fibrosis
17%
Prevalence
16%
Chronic Hepatitis B
16%
Acute on Chronic Liver Failure
16%
Human Immunodeficiency Virus
16%
Hepatitis C
14%
Cross Sectional Study
13%
Chronic Hepatitis C
13%
Retrospective Cohort Study
13%
Varices
11%
Obstructive Jaundice
11%
Bleeding
11%
Liver Cancer
11%
Disease Burden
10%
Neoplasm
10%
Platelet
10%
Survival Rate
10%
Health Care Cost
10%
Decompensated Liver Cirrhosis
9%
Aspartate Aminotransferase
9%
Endoscopy
9%
Scoring System
9%
Disease Exacerbation
9%
Biliary Tract Drainage
9%
Public Health
9%
Clinical Significance
9%
Disease
8%
Hepatology
8%
Fatty Liver
8%
Pancreas Cancer
8%
Immunosuppressive Treatment
8%
Bacterial Infection
8%
Endoscopic Retrograde Cholangiopancreatography
8%
Systemic Therapy
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
65%
Liver Cirrhosis
41%
Nonalcoholic Fatty Liver
32%
Hepatitis C Virus
29%
Hepatitis C
29%
Infection
27%
Liver Fibrosis
27%
Hepatitis B
27%
Diseases
26%
Fibrosis
24%
HIV
21%
Acute on Chronic Liver Failure
20%
Hepatitis B Virus
18%
Prevalence
17%
Chronic Hepatitis C
17%
Liver Disease
17%
Chronic Hepatitis B
16%
Portal Hypertension
15%
Fatty Liver
13%
Sofosbuvir
12%
Obstructive Jaundice
11%
Orosomucoid
11%
Alpha Fetoprotein
11%
Ribavirin
11%
Aspartate Aminotransferase
10%
Survival Rate
10%
Liver Cancer
10%
Virus Hepatitis
9%
Biological Marker
9%
Immunosuppressive Agent
9%
Antiviral Therapy
8%
Aminotransferase
8%
Chronic Liver Disease
8%
Hemodialysis
7%
Overall Survival
7%
Binding Protein
7%
Protein P53
7%
Cross-Sectional Study
7%
Malignant Neoplasm
7%
Sepsis
7%
Steatosis
7%
Alanine Aminotransferase
7%
Neoplasm
7%
Daclatasvir
7%
Chronic Hepatitis
6%
Peginterferon
6%
Tumor Necrosis Factor
6%
Disease Exacerbation
6%
Cohort Study
5%
Decompensated Liver Cirrhosis
5%